Avridine
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 524315

CAS#: 35607-20-6

Description: Avridine is a potent synthetic adjuvant that can induce arthritis. It is an immunomodulator and interferon-inducing agent.


Chemical Structure

img
Avridine
CAS# 35607-20-6

Theoretical Analysis

MedKoo Cat#: 524315
Name: Avridine
CAS#: 35607-20-6
Chemical Formula: C43H90N2O2
Exact Mass: 666.70
Molecular Weight: 667.190
Elemental Analysis: C, 77.41; H, 13.60; N, 4.20; O, 4.80

Price and Availability

Size Price Availability Quantity
5mg USD 270 2 Weeks
10mg USD 410 2 Weeks
25mg USD 710 2 Weeks
Bulk inquiry

Synonym: Avridine; CP 20961; CP-20,961; UNII-P9J7O7YNSW; Avridinum [Latin]; BRN 2227682;

IUPAC/Chemical Name: Ethanol, 2,2'-((3-(dioctadecylamino)propyl)imino)bis-

InChi Key: WXNRAKRZUCLRBP-UHFFFAOYSA-N

InChi Code: InChI=1S/C43H90N2O2/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-36-44(38-35-39-45(40-42-46)41-43-47)37-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h46-47H,3-43H2,1-2H3

SMILES Code: N(CCCN(CCO)CCO)(CCCCCCCCCCCCCCCCCC)CCCCCCCCCCCCCCCCCC

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO, not in water

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 667.19 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Vingsbo C, Jonsson R, Holmdahl R. Avridine-induced arthritis in rats; a T cell-dependent chronic disease influenced both by MHC genes and by non-MHC genes. Clin Exp Immunol. 1995 Mar;99(3):359-63. doi: 10.1111/j.1365-2249.1995.tb05558.x. PMID: 7882557; PMCID: PMC1534209.


2: Brun JG, Håland G, Haga HJ, Fagerhol MK, Jonsson R. Effects of calprotectin in avridine-induced arthritis. APMIS. 1995 Mar;103(3):233-40. doi: 10.1111/j.1699-0463.1995.tb01100.x. PMID: 7755980.


3: Fatunmbi OO, Newman JA, Sivanandan V, Halvorson DA. Enhancement of antibody response of turkeys to trivalent avian influenza vaccine by positively charged liposomal avridine adjuvant. Vaccine. 1992;10(9):623-6. doi: 10.1016/0264-410x(92)90444-o. PMID: 1502840.


4: Rweyemamu MM, Umehara O, de Lucca-Neto D, Baltazar MC, Vicente FE, Medeiros- Neto Rda R. Efficacy of avridine as an adjuvant for Newcastle disease virus antigen in chickens. Am J Vet Res. 1986 Jun;47(6):1243-8. PMID: 3729124.


5: Exon JH, Henningsen GM, Koller LD, Talcott PA. The selectivity of isoprinosine, NPT 15392, avridine and cyclophosphamide on multiple immune responses in rats. Int J Immunopharmacol. 1986;8(1):53-62. doi: 10.1016/0192-0561(86)90073-1. PMID: 2420733.


6: Megid J, Peraçolli MT, Curi PR, Zanetti CR, Cabrera WH, Vassao R, Ito FH. Effect of the bacillus of Calmette-Guérin, Propionibacter acnes and avridine as immunomodulators in antirabies vaccination of mice using the Fuenzalida-Palacios mouse brain vaccine. Vaccine. 1999 May 14;17(19):2446-52. doi: 10.1016/s0264-410x(98)00465-4. PMID: 10392627.


7: Roth JA, Kaeberle ML. Enhancement of lymphocyte blastogenesis and neutrophil function by avridine in dexamethasone-treated and nontreated cattle. Am J Vet Res. 1985 Jan;46(1):53-7. PMID: 3970443.


8: Berinstein A, Pérez Filgueira M, Schudel A, Zamorano P, Borca M, Sadir A. Avridine and LPS from Brucella ovis: effect on the memory induced by foot-and- mouth disease virus vaccination in mice. Vaccine. 1993 Oct;11(13):1295-301. doi: 10.1016/0264-410x(93)90098-i. PMID: 8296482.


9: Sadir AM, Zamorano PI, Romera A, Wigdorovitz A, Smitsaart E, Marangunich L, Schiappacassi C, Borca MV. Improvement of the immune response to foot and mouth disease virus vaccine in calves by using Avridine as adjuvant. Vet Immunol Immunopathol. 1999 Jul 1;69(1):11-22. doi: 10.1016/s0165-2427(99)00035-5. PMID: 10490231.


10: Talcott PA, Koller LD, Woodard LF, Whitbeck GA. Opposing effects of the interferon inducer, avridine: enhancement or suppression of tumor growth depending on treatment regimen. Int J Immunopharmacol. 1986;8(6):553-9. doi: 10.1016/0192-0561(86)90025-1. PMID: 2432025.


11: Côrtes JA, Rweyemamu MM, Ito FH, Umehara O, Medeiros Neto RR, De Lucca-Neto D, Baltazar MC, Vasconcellos SA, Vasconcellos ME. Immune response in cattle induced by inactivated rabies vaccine adjuvanted with aluminium hydroxide either alone or in combination with avridine. Rev Sci Tech. 1993 Sep;12(3):941-55. doi: 10.20506/rst.12.3.726. PMID: 8219344.


12: Knudsen RC, Card DM, Hoffman WW. Protection of guinea pigs against local and systemic foot-and-mouth disease after administration of synthetic lipid amine (Avridine) liposomes. Antiviral Res. 1986 Mar;6(2):123-33. doi: 10.1016/0166-3542(86)90032-x. PMID: 3010856.


13: Pérez Filgueira DM, Wigdorovitz A, Zamorano PI, Ostermann W, Fernández FM, Romera A, Borca MV, Sadir AM. Effect of Mycobacterium sp. wall and Avridine on the antibody response, IgG isotype profile and proliferative response induced by foot and mouth disease virus (FMDV) vaccination in cattle. Vaccine. 1999 Jan 28;17(4):345-52. doi: 10.1016/s0264-410x(98)00204-7. PMID: 9987173.


14: Pierce NF, Sacci JB Jr. Enhanced mucosal priming by cholera toxin and procholeragenoid with a lipoidal amine adjuvant (avridine) delivered in liposomes. Infect Immun. 1984 May;44(2):469-73. doi: 10.1128/iai.44.2.469-473.1984. PMID: 6370867; PMCID: PMC263543.


15: Joe B, Wilder RL. Animal models of rheumatoid arthritis. Mol Med Today. 1999 Aug;5(8):367-9. doi: 10.1016/s1357-4310(99)01528-2. PMID: 10475714.


16: Fatunmbi OO, Newman JA, Sivanandan V, Halvorson DA. Efficacy of avridine and liposomes as adjuvants for avian influenza virus antigens in turkeys. Avian Pathol. 1992;21(2):225-37. doi: 10.1080/03079459208418838. PMID: 18670935.


17: Lorentzen JC, Klareskog L. Comparative susceptibility of DA, LEW, and LEW.1AV1 rats to arthritis induced with different arthritogens: mineral oil, mycobacteria, muramyl dipeptide, avridine and rat collagen type II. Transplant Proc. 1997 May;29(3):1692-3. doi: 10.1016/s0041-1345(97)00018-3. PMID: 9142235.


18: Anderson AO, Rubin DH. Effect of Avridine on enteric antigen uptake and mucosal immunity to reovirus (1/Lang). Adv Exp Med Biol. 1985;186:579-90. doi: 10.1007/978-1-4613-2463-8_71. PMID: 4050592.


19: Wigdorovitz A, Zamorano P, Borca MV, Sadir AM. Modulation of the antigen presentation activity in foot and mouth disease virus (FMDV) vaccines by two adjuvants: avridine and a water soluble fraction of Mycobacterium sp. Vaccine. 1998 Oct;16(17):1627-32. doi: 10.1016/s0264-410x(98)00059-0. PMID: 9713938.


20: Anderson AO, Wood OL, King AD, Stephenson EH. Studies on anti-viral mucosal immunity with the lipoidal amine adjuvant avridine. Adv Exp Med Biol. 1987;216B:1781-90. PMID: 3425462.